Evidence map›Paper›PMID 18981261›Full record

ArticleAntimicrobial agents and chemotherapy2009

Sec- and Tat-dependent translocation of beta-lactamases across the Escherichia coli inner membrane.

N Pradel, J Delmas, L F Wu, C L Santini, R Bonnet

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 54 citations in OpenAlex.

  1. How social is social resistance?Essays in biochemistry · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. A novel mechanism of ceftolozane-tazobactam resistance inbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Twin-arginine transport complex plays an essential role inbioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Article
  10. OXA β-lactamases frombioRxiv : the preprint server for biology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. The biogenesis of β-lactamase enzymes.Microbiology (Reading, England) · 2022
    Review
  15. microLife · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

N PradelLaboratoire de Bactériologie, Faculté de Médecine, Université d'Auvergne, Clermont-Ferrand, France. nathalie.pradel@u-clermont1.fr
J Delmas
L F Wu
C L Santini
R Bonnet
Université Clermont Auvergne · FRCentre National de la Recherche Scientifique · FRLaboratoire de Chimie Bactérienne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

beta-Lactamases represent the major resistance mechanism of gram-negative bacteria against beta-lactam antibiotics. The amino acid sequences of these proteins vary widely, but all are located in the periplasm of bacteria. In this study, we investigated the translocation mechanism of representative beta-lactamases in an Escherichia coli model. N-terminal signal sequence analyses, antibiotic activity assay, and direct measurement of translocation of a green fluorescent protein (GFP) reporter fused to beta-lactamases revealed that most were exported via the Sec pathway. However, the Stenotrophomonas maltophilia L2 beta-lactamase was exported via the E. coli Tat translocase, while the S. maltophilia L1 beta-lactamase was Sec dependent. These results show the possible Tat-dependent translocation of beta-lactamases in the E. coli model system. In addition, the mutation of the cytoskeleton-encoding gene mreB, which may be involved in the spatial organization of penicillin-binding proteins, decreased the MIC of beta-lactams for beta-lactamase-producing E. coli. These findings provide new knowledge about beta-lactamase translocation, a putative new target for addressing beta-lactamase-mediated resistance.

Indexed as

Amoxicillinbeta-LactamasesCefotaximeCeftazidimeCephalothinEscherichia coliEscherichia coli ProteinsGreen Fluorescent ProteinsMicrobial Sensitivity TestsPiperacillinProtein TransportAmoxicillinbeta-lactamase L1beta-lactamase L2beta-LactamasesCefotaximeCeftazidimeCephalothinEscherichia coli ProteinsGreen Fluorescent ProteinsPiperacillin

Identifiers

PMID18981261
PMCPMC2612164
OpenAlexW2097181820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.